Kristen Krupa

Dr. Kristen Krupa

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
NBNicholas J. Braun
Nicholas J. Braun
MDMadeleine C. DeBrosse
Madeleine C. DeBrosse
SHSaber M. Hussain
Saber M. Hussain
KKKristen Krupa
Kristen Krupa

1 October 2018 in Journal of Toxicology
Verified
Journal Article
Open access
PDF file
CLClaudia J. Labrador-Rached
Claudia J. Labrador-Rached
RBRebecca T. Browning
Rebecca T. Browning
LBLaura K. Braydich-Stolle
Laura K. Braydich-Stolle
KKKristen Krupa
Kristen Krupa
Due to their distinctive physicochemical properties, platinum nanoparticles (PtNPs) have emerged as a material of interest for a number of biomedical therapeutics. However, in some instances NP exposure has been correlated to health and safety concerns, including cytotoxicity, activation of cellular stress, and modification to normal cell functionality. As PtNPs have induced differential cellular responses in vitro, the goal of this study was to further characterize the behavior and toxicological potential of PtNPs within a HepG2 liver model. This study identified that a high PtNP dosage induced HepG2 cytotoxicity. However, lower, subtoxic PtNP concentrations were able to elicit multiple stress responses, secretion of proinflammatory cytokines, and modulation of insulin-like growth factor-1 dependent signal transduction. Taken together, this work suggests that PtNPs would not be overtly toxic for acute exposures, but sustained cellular interactions might produce long term health consequences.

1 November 2014 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
KKKristen Krupa
Kristen Krupa
EMElizabeth I. Maurer
Elizabeth I. Maurer
SHSaber M. Hussain
Saber M. Hussain

24 September 2015 in Applied Nanoscience
Verified
Journal Article
Open access
PDF file
ALAlexandra O. Luby
Alexandra O. Luby
EBEmily K. Breitner
Emily K. Breitner
KKKristen Krupa
Kristen Krupa
Due to their advantageous characteristics, gold nanoparticles (AuNPs) are being increasingly utilized in a vast array of biomedical applications. However, the efficacy of these procedures are highly dependent upon strong interactions between AuNPs and the surrounding environment. While the field of nanotechnology has grown exponentially, there is still much to be discovered with regards to the complex interactions between NPs and biological systems. One area of particular interest is the generation of a protein corona, which instantaneously forms when NPs encounter a protein-rich environment. Currently, the corona is viewed as an obstacle and has been identified as the cause for loss of application efficiency in physiological systems. To date, however, no study has explored if the protein corona could be designed and advantageously utilized to improve both NP behavior and application efficacy. Therefore, we sought to identify if the formation of a preliminary protein corona could modify both AuNP characteristics and association with the HaCaT cell model. In this study, a corona comprised solely of epidermal growth factor (EGF) was successfully formed around 10-nm AuNPs. These EGF-AuNPs demonstrated augmented particle stability, a modified corona composition, and increased deposition over stock AuNPs, while remaining biocompatible. Analysis of AuNP dosimetry was repeated under dynamic conditions, with lateral flow significantly disrupting deposition and the nano-cellular interface. Taken together, this study demonstrated the plausibility and potential of utilizing the protein corona as a means to influence NP behavior; however, fluid dynamics remains a major challenge to progressing NP dosimetry.

1 October 2013 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
MDMadeleine C. DeBrosse
Madeleine C. DeBrosse
KKKristen Krupa
Kristen Krupa
EUEmily A. Untener
Emily A. Untener
DCDonald A. Comfort
Donald A. Comfort
SHSaber M. Hussain
Saber M. Hussain

5 September 2015 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
EBEmily K. Breitner
Emily K. Breitner
SHSaber M. Hussain
Saber M. Hussain
KKKristen Krupa
Kristen Krupa
Due to their distinctive physicochemical properties, nanoparticles (NPs) have proven to be extremely advantageous for product and application development, but are also capable of inducing detrimental outcomes in biological systems. Standard in vitro methodologies are currently the primary means for evaluating NP safety, as vast quantities of particles exist that require appraisal. However, cell-based models are plagued by the fact that they are not representative of complex physiological systems. The need for a more accurate exposure model is highlighted by the fact that NP behavior and subsequent bioresponses are highly dependent upon their surroundings. Therefore, standard in vitro models will likely produce inaccurate NP behavioral analyses and erroneous safety results. As such, the goal of this study was to develop an enhanced in vitro model for NP evaluation that retained the advantages of cell culture, but implemented the key physiological variables of accurate biological fluid and dynamic flow. In this study, a cellular microenvironment was modeled and created after an inhalation exposure scenario. This system comprised of A549 lung epithelial cells, artificial alveolar fluid (AAF), and biologically accurate dynamic flow. Under the influence of microenvironment variables, tannic acid coated gold NPs (AuNPs) displayed modulated physicochemical characteristics, including increased agglomeration, disruption of the spectral signature, and decreased rate of ionic dissolution. Furthermore, AuNP deposition efficiency, internalization patterns, and the nano-cellular interface varied as a function of fluid composition and flow condition. AAF incubation simultaneously influenced both AuNPs and cellular behavior, through excessive NP agglomeration and alteration to A549 morphology. Dynamic flow targeted the nano-cellular interface, with differential responses including modified deposition, internalization patterns, and cellular elongation. Lastly, the biocompatibility of the system was verified to ensure cellular health following AAF exposure and fluid dynamics. This study confirmed the feasibility of improving standard in vitro models through the incorporation of physiological variables. Utilization of this enhanced system demonstrated that to elucidate true NP behavior and accurately gauge their cellular interactions, assessments should be carried out in a more complex and relevant biological exposure model.